Hydralazine-Isosorbide Fixed Combination 37.5/20mg Tablets from Canada
Combination tablets with hydralazine 37.5mg and isosorbide dinitrate 20mg for heart failure in African-American patients (BiDil). Classified under HTS 3004.90.92.20 due to primary hydralazine content as specified cardiovascular medicament.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Except as provided in heading 9903.04.61, patented pharmaceutical articles as provided for in subdivisions (c) and (d) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Justify principal active (hydralazine) for specific subheading classification
• Include interaction studies for fixed-dose combo approval